CSIMarket


Cytokinetics Incorporated  (NASDAQ: CYTK)
Other Ticker:  
 

Cytokinetics Incorporated

CYTK's Fundamental analysis








Looking into Cytokinetics Incorporated growth rates, revenue grew by 912.38 % in IV. Quarter 2024 from the same quarter a year ago. Ranking at No. 1700

Major Pharmaceutical Preparations industry recorded growth of revenues by 11.85 %

Cytokinetics Incorporated net loss increased from $-137 millions, to $-150 millions in IV. Quarter 2024,

More on CYTK's Growth


Cytokinetics Incorporated
realized a net loss in trailing twelve months.

Cytokinetics Incorporated realized cash reduction of $ -0.16 per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 245.28.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.27.


More on CYTK's Valuation
 
 Total Debt (Millions $) 105
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 131,021
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 4.17
 Tangible Book Value (Per Share $) -1.21

Cytokinetics Incorporated
realized net loss in trailing twelve months.

Cytokinetics Incorporated realized cash outflow of $ -0.16per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 245.28.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.27.


More on CYTK's Valuation

  Market Capitalization (Millions $) 4,531
  Shares Outstanding (Millions) 112
  Employees 141
  Revenues (TTM) (Millions $) 18
  Net Income (TTM) (Millions $) -590
  Cash Flow (TTM) (Millions $) -18
  Capital Exp. (TTM) (Millions $) -4
  Total Debt (Millions $) 105
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 131,021
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) 4.17
  Tangible Book Value (Per Share $) -1.21

  Market Capitalization (Millions $) 4,531
  Shares Outstanding (Millions) 112
  Employees 141
  Revenues (TTM) (Millions $) 18
  Net Income (TTM) (Millions $) -590
  Cash Flow (TTM) (Millions $) -18
  Capital Exp. (TTM) (Millions $) -4





  Ratio
   Capital Ratio (MRQ) 6.89
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 0.01
  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com